We are live on ! Find out more
PACB icon

Pacific Biosciences
PACB

81 hedge funds and large institutions have $184M invested in Pacific Biosciences in 2013 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 37 increasing their positions, 18 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

199% more call options, than puts

Call options by funds: $454K | Put options by funds: $152K

183% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 6

147% more capital invested

Capital invested by funds: $74.4M → $184M (+$109M)

106% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 18

14% more funds holding

Funds holding: 71 → 81 (+10)

Holders
81
Holders Change
+10
Holders Change %
+14.08%
% of All Funds
2.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
37
Reduced
18
Closed
6
Calls
$454K
Puts
$152K
Net Calls
+$302K
Net Calls Change
+$267K

Top Buyers

Rank Fund Capital Flow
1
MC
Maverick Capital
Texas
+$7.92M
2
Millennium Management
Millennium Management
New York
+$5.81M
3
BFA
BlackRock Fund Advisors
California
+$1.28M
4
RFC
Russell Frank Company
Washington
+$1.07M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$737K

Top Sellers

Rank Fund Capital Flow
1
VAM
Visium Asset Management
New York
-$3.45M
2
RG
Redmile Group
California
-$3.04M
3
BCM
Bridgeway Capital Management
Texas
-$972K
4
Nomura Holdings
Nomura Holdings
Japan
-$788K
5
MHP
Manatuck Hill Partners
Connecticut
-$506K
Name Holding Trade Value Shares
Change 		Change in
Stake
BNP Paribas Financial Markets
26
BNP Paribas Financial Markets
France
$979K -$24.7K -7,120 -4%
SIM
27
Spark Investment Management
New York
$961K +$261K +75,200 +76%
BIM
28
BlackRock Investment Management
Delaware
$912K +$32.8K +9,442 +6%
SG Americas Securities
29
SG Americas Securities
New York
$888K +$1.62K +466 +0.3%
Deutsche Bank
30
Deutsche Bank
Germany
$888K +$334K +96,203 +148%
CS
31
Credit Suisse
Switzerland
$840K +$380K +109,346 +256%
Invesco
32
Invesco
Georgia
$835K -$346K -99,760 -40%
WMSA
33
Weiss Multi-Strategy Advisers
New York
$828K -$69.4K -20,000 -12%
NFA
34
Nationwide Fund Advisors
Ohio
$793K +$368K +105,980 +283%
Jacobs Levy Equity Management
35
Jacobs Levy Equity Management
New Jersey
$751K +$148K +42,690 +46%
BIM
36
Bogle Investment Management
Massachusetts
$692K +$436K +125,465 New
SIM
37
SSI Investment Management
California
$645K +$405K +116,710 New
Nomura Holdings
38
Nomura Holdings
Japan
$584K -$788K -227,138 -68%
PPA
39
Parametric Portfolio Associates
Washington
$561K +$15.5K +4,454 +5%
Charles Schwab
40
Charles Schwab
California
$501K – – –
AllianceBernstein
41
AllianceBernstein
Tennessee
$487K -$250K -71,885 -45%
D.E. Shaw & Co
42
D.E. Shaw & Co
New York
$487K +$123K +35,501 +68%
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$476K +$29K +8,358 +11%
Morgan Stanley
44
Morgan Stanley
New York
$430K +$213K +61,478 +375%
Susquehanna International Group
45
Susquehanna International Group
Pennsylvania
$426K +$168K +48,523 +170%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$395K -$1.43K -411 -0.6%
T. Rowe Price Associates
47
T. Rowe Price Associates
Maryland
$349K -$69.4K -20,000 -24%
Jane Street
48
Jane Street
New York
$333K +$210K +60,410 New
ProShare Advisors
49
ProShare Advisors
Maryland
$295K +$53.9K +15,523 +41%
TA
50
Teachers Advisors
New York
$279K -$1.27K -365 -0.7%
1
2
3 4

PACB Hedge Fund Activity: Q3 2013 in Review

81 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Pacific Biosciences (PACB) for Q3 2013, worth a combined $184M — up 147% from $74.4M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new PACB positions and 6 closed out — a net gain of 11 holders — while 37 added to existing stakes and 18 trimmed.

The largest buyer was Maverick Capital, adding an estimated $7.92M. The largest seller was Visium Asset Management, cutting an estimated $3.45M.

  • 81 institutional investors held Pacific Biosciences (PACB) as of Q3 2013, up from 71 in Q2 2013.
  • Funds reported $184M of Pacific Biosciences stock for Q3 2013, up 147% quarter-over-quarter.
  • 17 funds opened new Pacific Biosciences positions in Q3 2013 and 6 closed out, a net change of +11 holders.
  • The largest Pacific Biosciences buyer in Q3 2013 was Maverick Capital, an estimated $7.92M added.
  • The largest Pacific Biosciences seller in Q3 2013 was Visium Asset Management, an estimated $3.45M sold.

Based on aggregated 13F filings for Q3 2013.